The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Open accessAbstract
Bone erosion is a central feature of rheumatoid arthritis and is associated with disease severity and poor functional outcome. Erosion of periarticular cortical bone, the typical feature observed on plain radiographs in patients with rheumatoid arthritis, results from excessive local bone resorption and inadequate bone formation. The main triggers of articular bone erosion are synovitis, including the production of proinflammatory cytokines and receptor activator of nuclear factor κB ligand (RANKL), as well as antibodies directed against citrullinated proteins. Indeed, both cytokines and autoantibodies stimulate the differentiation of bone-resorbing osteoclasts, thereby stimulating local bone resorption. Although current antirheumatic therapy inhibits both bone erosion and inflammation, repair of existing bone lesions, albeit physiologically feasible, occurs rarely. Lack of repair is due, at least in part, to active suppression of bone formation by proinflammatory cytokines. This Review summarizes the substantial progress that has been made in understanding the pathophysiology of bone erosions and discusses the improvements in the diagnosis, monitoring and treatment of such lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TNF-α can also indirectly increase RANKL expression and affect osteoclast differentiation by activating osteoblasts, B cells, and T cells [88].”
From Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature (2024) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“RANKL-dependent pathways activated by pro-inflammatory cytokines can induce osteoclast formation, therefore, enhancing osteoclast activity [87, 88].”
From Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature (2024) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Self-citationOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138461 · Cited by 4,959
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. A. (2007) · Nature reviews. Immunology · doi:10.1038/nri2094 · Cited by 2,575
Self-citationOsteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Flagged first, then by citations
Research works printed but not linked: 2
- Baker, W. M. The formation of abnormal synovial cysts in the connection with the joints. St Bartolomews Hospital Reports 21, 177–190 (1855).
- Sato, K. et al. TH17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673–2682 (2006). · DOI · Paper page
Cited by
Sorted by citations
Items 501–600 of 946
Inflammation‐Induced Bone Loss in the Rheumatic Diseases
Gravallese, E. M., & Goldring, S. R. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch58 · Cited by 11
Self-citationStructural integrity versus radiographic progression in rheumatoid arthritis
Favalli, E. G., Becciolini, A., & Biggioggero, M. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000064 · Cited by 11
Zhao, M., Tse, J. J., Kuczynski, M. T., Brunet, S. C., Yan, R., Engelke, K., Peters, M., van den Bergh, J. P., van Rietbergen, B., Stok, K. S., et al. (2022) · Bone · doi:10.1016/j.bone.2022.116571 · Cited by 10
Managing psoriatic arthritis in different clinical scenarios
Queiró, R., Loredo, M., Braña, I., Pardo, E., Alonso, S., & Alpéri, M. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2249235 · Cited by 10
Chen, N., Diao, C., Huang, X. H., Tan, W., Chen, Y.-B., Qian, X.-Y., Gao, J., & Zhao, D. (2023) · Mediators of Inflammation · doi:10.1155/2023/5057009 · Cited by 11
A brief overview of chikungunya-related pain
Gonçalves, W. A., de Sousa, C. D. F., Teixeira, M. M., & Souza, D. G. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177322 · Cited by 11
Aniss, N. N.-D., Zaazaa, A. M., & Saleh, M. R. A. (2019) · International Journal of Pharmacology · doi:10.3923/ijp.2020.33.46 · Cited by 10
von Mentzer, U., Corciulo, C., & Stubelius, A. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200037 · Cited by 10
Eckert, D., Rapp, F., Tsedeke, A. T., Kraft, D., Wente, I., Molendowska, J., Basheer, S., Langhans, M., Meckel, T., Friedrich, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817281 · Cited by 10
Liu, J., Wang, L., Fang, H., Wang, X., Wu, L., & Zhang, J. (2022) · Medicine · doi:10.1097/md.0000000000031788 · Cited by 10
Sales, L. P., Hounkpe, B. W., Perez, M. O., Caparbo, V. F., Domiciano, D. S., Borba, E. F., Schett, G. A., Figueiredo, C. P., & Pereira, R. M. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1251034 · Cited by 10
Self-citationPemetrexed Ameliorates Experimental Arthritis in Rats
Karataş, A., Koca, S. S., Özgen, M., Dağlı, A. F., Erman, F., Sahin, N., Şahin, K., & Isik, A. (2014) · Inflammation · doi:10.1007/s10753-014-0002-3 · Cited by 10
Whole grape alleviates inflammatory arthritis through inhibition of tumor necrosis factor
Stamer, D. K., Nizami, S. A., Lee, F. Y., & Soung, D. Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.018 · Cited by 10
LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients
Bernardes, M., Durães, C., Oliveira, A., Martins, M. J., Lucas, R., Costa, L. M. S. F., Pereira, J. G. L., Ramos, I. M., Machado, J. C., & Simões-Ventura, F. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4625-3 · Cited by 10
Sun, X., Wang, Y., Zhang, M., & Wang, Q. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0541-6 · Cited by 10
Identification of a Novel Role for Foxo3 Isoform2 in Osteoclastic Inhibition
Xu, C., Vitone, G., Inoue, K., Ng, C., & Zhao, B. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900707 · Cited by 10
Depression and severity of articular destruction in patients with rheumatoid arthritis
Анатольевич, А. А., Lisitsyna, T. A., Veltishchev, D. Y., Seravina, O., Kovalevskaya, O. B., Glukhova, S. I., & Nasonov, E. L. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.05.000624 · Cited by 10
Dimitrijević, M., Arsenović-Ranin, N., Bufan, B., Nacka-Aleksić, M., Kosec, D. J., Pilipović, I., Kotur‐Stevuljević, J., Simić, L., Sopta, J. P., & Leposavić, G. (2020) · Inflammation · doi:10.1007/s10753-020-01302-0 · Cited by 10
Zeng, L., Li, C., Jiang, H., Yan, C., Li, Z., Xu, F., & Liu, R. (2021) · BioMed Research International · doi:10.1155/2021/6613527 · Cited by 10
Chatzidionysiou, K., Cîrciumaru, A., Réthi, B., Joshua, V., Engström, M., Hensvold, A. H., af Klint, E., & Catrina, A. I. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001662 · Cited by 10
Rothschild, B. M. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4001-x · Cited by 10
Pang, Q., Xu, Y., Qi, X., Huang, L., Hung, V. W.-Y., Xu, J., Liao, R., Hou, Y., Jiang, Y., yu, W. S., et al. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05168-3 · Cited by 10
Tanaka, Y., Soen, S., Ishiguro, N., Yamanaka, H., Yoneda, T., Tanaka, S., Ohira, T., Nitta, T., Okubo, N., Genant, H. K., et al. (2020) · RMD Open · doi:10.1136/rmdopen-2020-001249 · Cited by 10
Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?
Sims, N. A., & Romas, E. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0861-5 · Cited by 10
Alterations in bone fracture healing associated with TNFRSF signaling pathways
Dong, Y., Zhou, H., Alhaskawi, A., Wang, Z., Lai, J., Abdullah Ezzi, S. H., Kota, V. G., Abdulla Hasan Abdulla, M. H., Sun, Z., & Lu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905535 · Cited by 9
Sellin, M., Klinder, A., Bergschmidt, P., Bader, R., & Jonitz‐Heincke, A. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01103-3 · Cited by 10
Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?
Xu, C., Jing, W., Liu, C., Yuan, B., Zhang, X., Liu, L., Zhang, F., Chen, P., Liu, Q., Wang, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343325 · Cited by 11
Jiao, Y., Wang, Z., Diao, W., Geng, Q., Wang, X., Cao, X., Shi, T., Xu, J., Zhao, L., Wang, Z., et al. (2025) · Engineering · doi:10.1016/j.eng.2025.03.014 · Cited by 9
Liu, H., Wan, H., Zhang, A., Ouyang, Y., Lu, X., Wu, M., Hu, N., Pan, J., Guo, D., Li, Z. A., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03501-z · Cited by 10
Zheng, Z., Dai, J., Pan, X., Xiang, J., You, P., Zhang, H., & Luo, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145306 · Cited by 9
Liu, Y., Wang, X., Lu, J., Huang, H., Qiu, Y., & Peng, Y.-P. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03659-9 · Cited by 9
Bergmann, B., Jirholt, P., Henning, P., Lindholm, C., Ohlsson, C., McInnes, I. B., Lerner, U. H., & Gjertsson, I. (2018) · Infection and Immunity · doi:10.1128/iai.00960-17 · Cited by 9
Resende, A. B. L., Monteiro, G. P., Ramos, C. C., Lopes, G. S., Broekman, L. A., & de Souza, J. M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16935 · Cited by 9
ABATACEPT FOR RHEUMATOID ARTHRITIS: A NOVEL FORMULATION, NEW MECHANISMS, NEW POSSIBILITIES
Nasonov, E. L. (2015) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2015-522-541 · Cited by 9
Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow
Schiff, M. H. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-015-0029-0 · Cited by 9
Martin, E. S., Schneeberger, E. E., Aranda, F. M., Wingeyer, S. D. P., Valerio, M. D. C., Correa, M. D. L. Á., Pra, F. D., Martínez, L., Remondino, G., Larrañaga, G. F. D., et al. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3380-0 · Cited by 9
Ghozlani, I., Mounach, A., Ghazi, M., Kherrab, A., Niamane, R., & Maghraoui, A. E. (2017) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2017.06.007 · Cited by 9
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement
Cici, D., Corrado, A., Rotondo, C., Colìa, R., & Cantatore, F. P. (2020) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-021-09275-w · Cited by 9
Myeloid IPMK Promotes the Resolution of Serum Transfer-Induced Arthritis in Mice
Ahn, H., Roh, J. S., Lee, S., Beon, J., Lee, B., Sohn, D. H., & Kim, S. (2021) · Animal Cells and Systems · doi:10.1080/19768354.2021.1952305 · Cited by 9
González-Sánchez, H. M., Baek, J.-H., Weinmann‐Menke, J., Ajay, A. K., Charles, J. F., Noda, M., Franklin, R. A., Rodríguez-Morales, P., & Kelley, V. R. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00772-0 · Cited by 10
Kim, J., Cheon, Y., Ahn, S., Kwak, S. C., Chung, C. H., Lee, C. H., & Lee, M. S. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03694-y · Cited by 9
Yeganeh, F., Mousavi, S. M. J., Hosseinzadeh-Sarband, S., Ahmadzadeh, A., Bahrami‐Motlagh, H., Hoseini, M. H. M., Sattari, M., Sohrabi, M.-R., Pouriran, R., & Dehghan, P. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4268-y · Cited by 9
HLA-DRB1 Haplotypes, Shared Epitope, and Disease Outcomes in US Veterans with Rheumatoid Arthritis
Ming, Z., Mauer, L., Sayles, H. R., Cannon, G. W., Reimold, A. M., Kerr, G. S., Baker, J. F., Thiele, G. M., England, B. R., & Mikuls, T. R. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.180724 · Cited by 9
Chen, C., Li, H.-P., Chao, Y., Tu, M., Yen, C., Lan, Y., Yang, S., Chong, K., Lin, C., & Chen, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.721594 · Cited by 9
Qin, Y., Shirakawa, J., Xu, C., Chen, R., Xu, Y., Ng, C., Nakano, S., Elguindy, M. M., Deng, Z., Prasanth, K. V., et al. (2024) · eLife · doi:10.7554/elife.98900 · Cited by 9
Kim, H. J., Ryu, K., Kim, M. O., Kim, M. O., Lee, J. H., Song, M., Youn, Y.-J., Pokhrel, N. K., Kim, J., Kim, J., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4478 · Cited by 8
Nesfatin-1 stimulates BMP5 expression and osteoclastogenesis in rheumatoid arthritis
Chang, J., Lin, Y., Tsai, C., Liu, S., He, X.-Y., Wu, Y., Huang, C., & Tang, C. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115687 · Cited by 8
Vandebeek, D., Lodewijckx, E., Hoovels, L. V., Verschueren, P., & Bossuyt, X. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119928 · Cited by 8
The role of Nrf2 in immune cells and inflammatory autoimmune diseases: a comprehensive review
Xu, W., Yang, C., & Huang, A. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2401518 · Cited by 8
Melittin: A promising therapeutic agent for rheumatoid arthritis treatment
Huang, R., He, X., Meng, Q., Yan, G., Dong, K., & Tian, Y. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108335 · Cited by 8
Imaging Updates in Rheumatoid Arthritis
Walter, W. R., & Samim, M. (2025) · Seminars in Musculoskeletal Radiology · doi:10.1055/s-0045-1802952 · Cited by 8
Iaconis, A., Molinari, F., Fusco, R., & Paola, R. D. (2025) · Biomedicines · doi:10.3390/biomedicines13071708 · Cited by 9
Zhang, X., Meng, S., Xiao, Y., Liu, Y., Tang, Z., Li, A., Wu, K., Cheng, C., Mao, Z., Guo, H., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123926 · Cited by 10
Qiu, H., Wen, R., Dong, P., Shui, S., Dai, L., Zou, X., Lan, F., & Wu, Y. (2026) · ACS Nano · doi:10.1021/acsnano.6c00168 · Cited by 9
Badawy, T., Kyumoto‐Nakamura, Y., Uehara, N., Zhang, J.-Q., Sonoda, S., Hiura, H., Yamaza, T., Kukita, A., & Kukita, T. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0179-4 · Cited by 8
Associations of vascular and bone status in arthritis patients
Pusztai, A., Hamar, A., Czókolyová, M., Gulyás, K., Horváth, Á., Végh, E., Pethő, Z., Szamosi, S., Balogh, E., Bodnár, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99071-9 · Cited by 8
Henchie, T. F., Gravallese, E. M., Bredbenner, T. L., & Troy, K. L. (2019) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2019.1607315 · Cited by 8
Self-citationFassio, A., Adami, G., Idolazzi, L., Giollo, A., Viapiana, O., Vantaggiato, E., Benini, C., Rossini, M., Dejaco, C., & Gatti, D. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00551 · Cited by 8
He, C., Yang, W., Wen, Y., Li, T., Hu, E., Zeng, S., & Xiong, X. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03663-5 · Cited by 8
Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis
Ng, C., Qin, Y., Xia, Y., Hu, X., & Zhao, B. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300317 · Cited by 8
Atkinson, S. M., Bleil, J., Maier, R., Kühl, A. A., Thorn, M., Serikawa, K. A., Fox, B. A., Kruse, K., Haase, C., Skov, S., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0931-3 · Cited by 8
Sharpin Controls Osteogenic Differentiation of Mesenchymal Bone Marrow Cells
Jeschke, A., Catalá-Lehnen, P., Sieber, S., Bickert, T., Schweizer, M., Koehne, T., Wintges, K., Marshall, R. P., Mautner, A., Duchstein, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402392 · Cited by 8
Citric acid and lactic acid have a synergetic effect on absorbing the bone mineral crystal
Geng, Z., Ma, L., Li, Z., Cui, Z., Zhu, S., Liang, Y., & Yang, X. (2017) · Materials Letters · doi:10.1016/j.matlet.2017.12.043 · Cited by 8
Peña, M., Quirós, J., Pérez‐Fernández, E., Crespí-Villarías, N., Costa, E. D., García-Vadillo, A., Espinosa, M. A., Villa, C. C. M., Hita, J. L. M., Martínez-Prada, C., et al. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190182 · Cited by 8
Henning, P., Movérare‐Skrtic, S., Westerlund, A., de Souza, P. P. C., Marcelino, T. F., Nilsson, K. H., Shahawy, M. E., Ohlsson, C., & Lerner, U. H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s323435 · Cited by 9
Watanabe, K., Chiba, K., Shiraishi, K., Iida, T., Iwamoto, N., Yonekura, A., Kawakami, A., & Osaki, M. (2024) · Bone · doi:10.1016/j.bone.2024.117250 · Cited by 7
Myeloid-specific deletion of autotaxin inhibits rheumatoid arthritis and osteoclastogenesis
Heo, G., Jeong, S., Park, S., Kim, S. J., Lee, Y., Woo, S. J., Kim, K., Park, B., Rhee, S. H., & Im, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1481699 · Cited by 7
Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases
Yang, Y.-S., Kim, M., Chaugule, S. R., Mayer, E., DeSouza, N. H., Ma, H., Xie, J., Lee, K., Li, S., Gravallese, E. M., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.008 · Cited by 8
Self-citationHodges, P. W., Fiore, N. T., Watkins, L. R., Klyne, D. M., Coppieters, M. W., & Grace, P. M. (2026) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2025.103484 · Cited by 9
Akasaka, D., Iguchi, S., Kaneko, R., Yoshiga, Y., Kajiwara, D., Nakachi, Y., Noma, N., Tanaka, K. F., Shimizu, A., & Hosoi, F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282117 · Cited by 9
Hmamouchi, I., Paruk, F., Tabra, S. A. A., Maatallah, K., Bouziane, A., Abouqal, R., Maidany, Y. E., Maghraoui, A. E., & Kalla, A. A. (2023) · Archives of Osteoporosis · doi:10.1007/s11657-023-01246-6 · Cited by 7
Du, C., Li, X., Chen, J., Luo, L., Yuan, C., Yang, J., Hao, X., & Gu, W. (2024) · Molecules · doi:10.3390/molecules29184395 · Cited by 7
Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis
Sabokbar, A., Afrough, S., Mahoney, D. J., Uchihara, Y., Swales, C. E., & Athanasou, N. A. (2017) · World Journal of Experimental Medicine · doi:10.5493/wjem.v7.i2.49 · Cited by 7
Maltby, S., Lochrin, A. J., Bartlett, B., Tay, H. L., Weaver, J., Poulton, I. J., Plank, M. W., Rosenberg, H. F., Sims, N. A., & Foster, P. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700927 · Cited by 7
Pseudoerosions of Hands and Feet in Rheumatoid Arthritis: Anatomic Concepts and Redefinition
Hirtler, L., Rath, C., Platzgummer, H., Aletaha, D., & Kainberger, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122174 · Cited by 7
Bone Wasn't Built in a Day: Destruction and Formation of Bone in the Rheumatic Diseases.
Gravallese, E. M. (2017) · Europe PMC (PubMed Central) · Cited by 7
Self-citationInfluence of Iguratimod on Bone Metabolism in Patients with Rheumatoid Arthritis: A Meta‐analysis
Deng, L., Yao, F., Tian, F., Luo, X., Yu, S., & Wen, Z. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/5684293 · Cited by 7
Adib, M., Taghadosi, M., Tahmasebi, M. N., Vaziri, A. S., Jamshidi, A., Mahmoudi, M., & Farhadi, E. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01094-9 · Cited by 7
Gandhi, Y., Kushwaha, V., Kumar, V., Rawat, H., Charde, V., Mishra, S. K., Singh, G., Soni, H., Kumar, R., Shakya, S. K., et al. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.109958 · Cited by 7
The Role of the Immune System in the Local and Systemic Bone Loss of Inflammatory Arthritis
Gravallese, E. M., Goldring, S. R., & Schett, G. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00013-x · Cited by 7
Self-citationKragstrup, T. W. (2016) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2016.1203022 · Cited by 7
Effect of inositol -stabilized arginine silicate on arthritis in a rat model
Şahin, K., Ojalvo, S. P., Akdemir, F., Orhan, C., Tuzcu, M., Şahin, N., Özercan, İ. H., Sylla, S., Koca, S. S., Yılmaz, İ., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.01.005 · Cited by 7
Cannabinoids in Autoimmune and Rheumatic Diseases
Navarini, L., Margiotta, D. P. E., Afflitto, G. G., & Afeltra, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00038-4 · Cited by 7
Li, C., Li, Y., Zeng, Q., Zhou, Y., Su, H., Han, Y., & Li, C. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2352757 · Cited by 8
Wang, H., Lee, Y., Cheng, I., Wang, S., Ji, J., Huo, A., & Hung, Y. (2025) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70204 · Cited by 6
Xin, P., Pei, S., Ma, N., & Xiao, L. (2025) · PeerJ · doi:10.7717/peerj.19661 · Cited by 7
Liu, Y., Zhang, P., Kong, W., Li, J., Yang, H., Bai, H., Fan, G., Cao, X., & Li, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1767601 · Cited by 9
Wu, S., Wu, X., Wang, T., Jiang, F., Hu, M.-W., Li, R., Liu, J., & Cai, L. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae015 · Cited by 6
Autophagy: regulating the seesaw of bone–fat balance
Zhang, B., Cui, J. R., Zhang, X., Pan, Z., Du, L., Ye, R., Wen, L., Zhai, W., Huang, L. H., Li, D., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1465092 · Cited by 6
Iseme, R. A., McEvoy, M., Kelly, B. J., Agnew, L. L., Walker, F. R., Boyle, M., & Attia, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/9407971 · Cited by 6
Koehler, M. I., Hartmann, E. S., Schluessel, S., Beck, F., Redeker, J. I., Schmitt, B., Unger, M., van Griensven, M., Summer, B., Fottner, A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102583 · Cited by 6
Zhao, M., He, H., & Yin, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.006 · Cited by 6
Cardona-Rincón, A. D., Acevedo-Godoy, M., Bello-Gualtero, J. M., Valle‐Oñate, R., Chalem, P., Perdomo, S. J., Miyared, A., Chila‐Moreno, L., Bautista‐Molano, W., & Romero‐Sánchez, C. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001391 · Cited by 6
Effective factors on Sharp Score in patients with rheumatoid arthritis: a retrospective study
Wen, J., Liu, J., Xin, L., Wan, L., Jiang, H., Sun, Y., Sun, Y., Wang, X., & Wang, J. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04742-3 · Cited by 6
Hasegawa, T. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1913883 · Cited by 6
Association among B lymphocyte subset and rheumatoid arthritis in a Chinese population
You, H., Cheng, M., Ma, C., Zheng, W., Jiang, Y. P., Chen, D., & Tang, Y. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02883-8 · Cited by 6
Zhou, Y., Zhao, Y., Xu, H., Zhao, X., Zhao, C., Zhou, T., & Zhang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.880350 · Cited by 6
Wang, X., Tang, Z., Huang, T., Hu, H., Zhao, Y., & Liu, Y. (2022) · Lara D. Veeken · doi:10.1093/rheumatology/keac515 · Cited by 6
Filipović, M., Flegar, D., Aničić, S., Šisl, D., Kelava, T., Kovačić, N., Šućur, A., & Grčević, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.994035 · Cited by 6
Septic Arthritis of the Knee in Children
Darraj, H., Hakami, K., Zogel, B. A., Maghrabi, R., & Khired, Z. A. (2023) · Cureus · doi:10.7759/cureus.45659 · Cited by 6
Metadata
- Authors
- Schett, G., & Gravallese, E.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Schett, Georg
- Venue
- Nature Reviews Rheumatology
- Published
- 2012-09-25
- Volume
- 8
- Issue
- 11
- Pages
- 656-664
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- PMC
- PMC4096779
- OpenAlex
- W2032362610
- Cited by
- 947
- References
- 124
- Citations by year
- 2026: 72 · 2025: 72 · 2024: 89 · 2023: 75 · 2022: 82 · 2021: 89 · 2020: 80 · 2019: 75 · 2018: 73 · 2017: 74 · 2016: 53 · 2015: 52 · 2014: 35 · 2013: 26
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- American College of Rheumatology Research and Education Foundation
- Rheumatology Research Foundation
- European Commission
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- National Institutes of Health (5r01ar055952-05)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR055952)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Keywords
- bone erosion, rheumatoid arthritis, bone resorption, osteoclasts, synovitis, inflammatory cytokines, RANKL, anti-citrullinated protein antibodies, bone formation, bone regeneration, radiographic erosions, antirheumatic therapy
- MeSH terms
- Animals, Arthritis, Rheumatoid, Bone Resorption, Cell Differentiation, Humans, Osteoclasts, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review